Blood · 2005 · 153 citations · 42 references
Life SciencesCell BiologyMolecular BiologyCell SignalingMolecular Cell BiologySignal TransductionCell Surface Receptor SignalingMembrane ReceptorsPlatelet ActivationPlatelet PhysiologyReceptor RegulationReceptor-mediated SignalingPlatelet Receptor BiologyPlatelet Receptor SignalingPlatelet Receptor-ligand InteractionsPlatelet Surface ReceptorsPlatelet-leukocyte InteractionsThrombopoietin Receptor AgonistsThrombopoietin Receptor Signaling
Ligand binding to the thrombopoietin receptor (TpoR) is thought to impose a dimeric receptor conformation(s) leading to hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Unlike other cytokine receptors, such as the erythropoietin receptor, TpoR contains an amphipathic KWQFP motif at the junction between the transmembrane (TM) and cytoplasmic domains. We show here that a mutant TpoR (delta5TpoR), where this sequence was deleted, is constitutively active. In the absence of ligand, delta5TpoR activates Jak2, Tyk2, STAT5, and mitogen-activated protein (MAP) kinase, but does not appear to induce STAT3 phosphorylation. Delta5TpoR induces hematopoietic myeloid differentiation in the absence of Tpo. In the presence of Tpo, the delta5TpoR mutant appears to enhance erythroid differentiation when compared with the Tpo-activated wild-type TpoR. Strikingly, individual substitution of K507 or W508 to alanine also induces constitutive TpoR activation, indicating that the K and W residues within the amphipathic KWQFP motif are crucial for maintaining the unliganded receptor inactive. These residues may be targets for activating mutations in humans. Such a motif may exist in other receptors to prevent ligand-independent activation and to allow signaling via multiple flexible interfaces.
42
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
Frédéric J. de Sauvage, Philip E. Hass, Susan D. Spencer et al. · Nature · 1994 · 1.3K citations
Medicine, Cell Biology, Hematology +11
Robert M. Hudziak, Joseph Schlessinger, Axel Ullrich · Proceedings of the National Academy of Sciences · 1987 · 630 citations · Full text